WEDNESDAY, Feb. 6, 2019 -- Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).
Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported.
TUESDAY, Jan. 15, 2019 -- A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.
The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in the past year despite taking standard medication, and they'd already tried an average of three of those drugs.
WEDNESDAY, Dec. 19, 2018 -- Researchers say they've identified a potential link between food allergies and flare-ups of multiple sclerosis.
"Our findings suggest that MS patients with allergies have more active disease than those without, and that this effect is driven by food allergies," said study author Dr. Tanuja Chitnis, an MS specialist, and colleagues.